Showing 1 - 20 results of 225 for search 'Dormond, Olivier' Narrow Search
3
Academic Journal

Superior Title: Gatterer, Constantin; Beitzke, Dietrich; Graf, Senta; Lenz, Max; Sunder-Plassmann, Gere; Mann, Christopher; Ponleitner, Markus; Manka, Robert; Fritschi, Daniel; Krayenbuehl, Pierre-Alexandre; Kamm, Philipp; Dormond, Olivier; Barbey, Frédéric; Monney, Pierre; Nowak, Albina (2023). Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease. Life, 13(5):1213.

File Description: application/pdf

Relation: https://www.zora.uzh.ch/id/eprint/255820/1/life_13_01213.pdf; info:pmid/37240859; urn:issn:2075-1729

6
Academic Journal

Alternate Title: Chaperone molecules: The example of Fabry disease (English)

Superior Title: In Nephrologie et Thérapeutique April 2021 17 Supplement:S11-S22

7
Academic Journal

Superior Title: Nowak, Albina; Dormond, Olivier; Monzambani, Véronique; Huynh-Do, Uyen; Barbey, Frédéric (2022). Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity. Molecular Genetics and Metabolism, 137(1-2):173-178.

File Description: application/pdf

Relation: https://www.zora.uzh.ch/id/eprint/228771/1/1_s2.0_S1096719222003900_main.pdf; info:pmid/36087505; urn:issn:1096-7192

9
eBook

Authors: Dormond, Olivier

Subject Terms: primary cilia, neurodegeneration, nutrient sensor, PI3K, transcriptomics, phosphorylation, metabolic reprogramming, autophagy, Alzheimer’s disease, rapalogs, liver, angiogenesis, mTOR complex, MBSCs, advanced biliary tract cancers, Medulloblastoma, epithelial to mesenchymal transition, AMPK, p70S6K, lipid metabolism, thyroid cancer, sodium iodide symporter (NIS)/SLC5A5, male fertility, anesthesia, illumina, mTOR inhibitor, miRNA, Hutchinson-Gilford progeria syndrome (HGPS), eIFs, Emery-Dreifuss muscular dystrophy (EDMD), glucose, AKT, oral cavity squamous cell carcinoma (OSCC), glucose and lipid metabolism, cellular signaling, aging, tumor microenvironment, rapamycin, leukemia, chloral hydrate, rapalogues, schizophrenia, T-cell acute lymphoblastic leukemia, senescence, lamin A/C, neurotoxicity, neurodevelopment, inhibitor, methamphetamine, pulmonary fibrosis, mTOR, mTOR inhibitors, combination therapy, proteolysis, fluid shear stress, tumour cachexia, biomarkers, synapse, gluconeogenesis, mTOR signal pathway, Sertoli cells, immunosenescence, miRNome, protein aggregation, senolytics, metabolism, NGS, mTORC2, mTORC1, metabolic diseases, IonTorrent, apoptosis, dopamine receptor, nocodazole, microenvironment, everolimus, acute myeloid leukemia, immunotherapy, spermatogenesis, bone remodeling, signalling, targeted therapy, ageing, therapy, NVP-BEZ235, fructose, physical activity, laminopathies, MC3T3-E1 cells, cell signaling, microRNA, cancer, lipolysis, melatonin, Parkinson’s disease, bic Book Industry Communication:M Medicine, R5-920

File Description: image/jpeg

16
Academic Journal

Superior Title: van Beijnum , J R , Weiss , A , Berndsen , R H , Wong , T J , Reckman , L C , Piersma , S R , Zoetemelk , M , de Haas , R , Dormond , O , Bex , A , Henneman , A A , Jimenez , C R , Griffioen , A W & Nowak-Sliwinska , P 2020 , ' Integrating phenotypic search and phosphoproteomic profiling of active kinases for optimization of drug mixtures for rcc treatment ' , Cancers , vol. 12 , no. 9 , pp. 1-19 . https://doi.org/10.3390/cancers12092697